Android Apple

The three-year decline in earnings for Amgen NASDAQ:AMGN) isn't encouraging, but shareholders are still up 50% over that period

By Yahoo! Finance   |   1 month ago
The three-year decline in earnings for Amgen NASDAQ:AMGN) isn't encouraging, but shareholders are still up 50% over that period

Amgen Inc. (NASDAQ: AMGN) shareholders saw a 13% drop in share price last week, yet the company's three-year returns were strong at 38%, surpassing the market index. Despite a decline in earnings per share, revenue growth of 6.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.